AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2015
Mar 13, 2015
30237_dirs_2015-03-13_89f09b43-f337-4e0c-b481-1b71334a89d6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2015-03-11
Reporting Person: Brecher Mark E (CMO, LabCorp Diagnostics)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-03-11 | Restricted Stock Unit | $ | A | 1230 | Acquired | Common Stock (1230) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: The Restricted Stock Units vest in three equal installments beginning on 3/11/2016.
F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 26
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Earnings Release
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Notice of Dividend Amount
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30